CoChat

Multidirectional characterization of cellular composition and spatial architecture in human multiple primary lung cancers

Open access
Wang, Yawei, Chen, Di, Liu, Yu, Shi, Daiwang, Duan, Chao, Li, Jinghan, Shi, Xiang, Zhang, Yong, Yu, Zhanwu, Sun, Nan, Wang, Wei, Ma, Yegang, Xu, Xiaohan, Otkur, Wuxiyar, Liu, Xiaolong, Xia, Tian, Qi, Huan, Piao, Hai-long, Liu, Hong-Xu · 2023 · Cell Death & Disease

The DOI matches its Crossref record; 51 of the 51 references it cites were found in a registry or an index.

Abstract

Multiple primary lung cancers (MPLCs) pose diagnostic and therapeutic challenges in clinic. Here, we orchestrated the cellular and spatial architecture of MPLCs by combining single-cell RNA-sequencing and spatial transcriptomics. Notably, we identified a previously undescribed sub-population of epithelial cells termed as CLDN2+ alveolar type II (AT2) which was specifically enriched in MPLCs. This subtype was observed to possess a relatively stationary state, play a critical role in cellular communication, aggregate spatially in tumor tissues, and dominate the malignant histopathological patterns. The CLDN2 protein expression can help distinguish MPLCs from intrapulmonary metastasis and solitary lung cancer. Moreover, a cell surface receptor−TNFRSF18/GITR was highly expressed in T cells of MPLCs, suggesting TNFRSF18 as one potential immunotherapeutic target in MPLCs. Meanwhile, high inter-lesion heterogeneity was observed in MPLCs. These findings will provide insights into diagnostic biomarkers and therapeutic targets and advance our understanding of the cellular and spatial architecture of MPLCs.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41419-023-05992-w

Cites

51 of 51 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig. 1 scRNA-seq based tumor heterogeneity overview of MPLCs. a Overview about the integrative data resources. b Number of cells in each sample after quality control. c Uniform Manifold Approximation and Projection (UMAP) of the 133923 cells based on scRNA-seq data. The cell types were annotated based on canonical cell type markers. d The proportions of different cell types within each measured sample. The y-axis represents the samples, and x-axis represents the percentage or total count. The proportions were estimated based on a bootstrap method, and represented in the form of mean ± s.d. The colors represent cell types. e The change of the cell type proportion between samples from different tumor lesions (red) or tumor-adjacent tissues (blue) within the same MPLCs patient. |·| means absolute value. Data represent mean ± s.d. t test, unpaired, one-sided. f Clustering both the samples collected by this study and the other LUAD tumor and adjacent normal tissue samples from an independent study (GEO dataset ID: GSE131907, n = 11 for both tumor and normal samples) based on the Spearman correlations between the cell type composition of two samples. See also Supplementary Fig. 2 for the clustering details. The sample names from GEO131907 begin with GEO, while the MPLC sample names begin with T or N. The letters L and R in the MPLC sample names represent left and right lung. g Boxplot of the correlations between different types of samples. t test, paired and one sided for comparing T-Within and N-Within, unpaired and two sided for the other comparisons. h The similarities between different samples within the same MPLCs patient. The similarity is based on the Spearman correlation coefficients between the average expressions of variable genes in two samples. MPLC multiple primary lung cancer, IPM intrapulmonary metastasis, ST spatial transcriptomics, IHC immunohistochemistry, TI tumor sample from the inferior lobe, TM tumor tissue from middle lobe, TS tumor tissue from superior lobe, NI normal tissue adjacent to TI, NM normal tissue adjacent to TM, NS normal tissue adjacent to TS, Log2FC log2-transformed fold change. N-within: correlations between normal samples within the same MPLCs patient. T-within: correlations between different tumor lesions within the same MPLCs patient. T-independent: correlations between different tumor tissues from different LUAD patients from GSE131907. corr: Spearman correlation coefficient between the cell type compositions of two samples.
Fig. 1 scRNA-seq based tumor heterogeneity overview of MPLCs. a Overview about the integrative data resources. b Number of cells in each sample after quality control. c Uniform Manifold Approximation and Projection (UMAP) of the 133923 cells based on scRNA-seq data. The cell types were annotated based on canonical cell type markers. d The proportions of different cell types within each measured sample. The y-axis represents the samples, and x-axis represents the percentage or total count. The proportions were estimated based on a bootstrap method, and represented in the form of mean ± s.d. The colors represent cell types. e The change of the cell type proportion between samples from different tumor lesions (red) or tumor-adjacent tissues (blue) within the same MPLCs patient. |·| means absolute value. Data represent mean ± s.d. t test, unpaired, one-sided. f Clustering both the samples collected by this study and the other LUAD tumor and adjacent normal tissue samples from an independent study (GEO dataset ID: GSE131907, n = 11 for both tumor and normal samples) based on the Spearman correlations between the cell type composition of two samples. See also Supplementary Fig. 2 for the clustering details. The sample names from GEO131907 begin with GEO, while the MPLC sample names begin with T or N. The letters L and R in the MPLC sample names represent left and right lung. g Boxplot of the correlations between different types of samples. t test, paired and one sided for comparing T-Within and N-Within, unpaired and two sided for the other comparisons. h The similarities between different samples within the same MPLCs patient. The similarity is based on the Spearman correlation coefficients between the average expressions of variable genes in two samples. MPLC multiple primary lung cancer, IPM intrapulmonary metastasis, ST spatial transcriptomics, IHC immunohistochemistry, TI tumor sample from the inferior lobe, TM tumor tissue from middle lobe, TS tumor tissue from superior lobe, NI normal tissue adjacent to TI, NM normal tissue adjacent to TM, NS normal tissue adjacent to TS, Log2FC log2-transformed fold change. N-within: correlations between normal samples within the same MPLCs patient. T-within: correlations between different tumor lesions within the same MPLCs patient. T-independent: correlations between different tumor tissues from different LUAD patients from GSE131907. corr: Spearman correlation coefficient between the cell type compositions of two samples.CC BY · PubMed Central
Fig. 2 Subclassification and characterization of epithelial cells in MPLCs. a Heatmap of CNV profiles estimated from scRNA-seq of tumor lesions from each patient. The vertical axis is arranged by origin patients, samples, cell malignant or not, and on the CNV-based clustering results. The horizontal axis displays all chromosomes in numerical order. kmCluster: the k-means clustering results of epithelial cells based on the CNV profiles. cellMN: whether the cell is malignant or not. b UMAP plot colored by the sub-populations of epithelial cells. c Dot plot of the expression of marker genes for the epithelial cell sub-populations. d Bar plot of the bootstrap proportions of epithelial cell sub-populations within each measured sample. e The epithelial cell sub-population proportions in tumor lesions (red) or the adjacent normal tissues (blue) from the four MPLC patients. Data represent mean ± s.d. **P < 0.01, t test, unpaired. f UMAP view of the clustering results (left) and CLDN2+ AT2 signatures (right) of epithelial cells from both the MPLCs patients and the dataset GSE131907. Batch effects were removed by harmony. The CLDN2+ AT2 signature was calculated based on the cell-wise gene set variation analysis, and the top15 ranked (based on P-values) marker genes for the CLDN2+ AT2 subtype were utilized as the signature gene set. g Pie plot of the data source of cells in Cluster 5 in (f). h Box plot of the differential expressions of CLDN2 between cells from the MPLC patients and GSE131907. Wilcox test, unpaired. i Immunohistochemistry (IHC) of CLDN2 expressions on the MPLCs samples. Samples NM_R_P2 and TM_R_P2 were taken as examples. Red border area was magnified and presented on the right. j Box plot of the differential CLDN2 IHC scores in MPLCs, IPM and solitary LUAD. Each IPM or MPLCs patient possessed two LUAD lesions at ipsilateral different lobes. Wilcox test, unpaired.
Fig. 2 Subclassification and characterization of epithelial cells in MPLCs. a Heatmap of CNV profiles estimated from scRNA-seq of tumor lesions from each patient. The vertical axis is arranged by origin patients, samples, cell malignant or not, and on the CNV-based clustering results. The horizontal axis displays all chromosomes in numerical order. kmCluster: the k-means clustering results of epithelial cells based on the CNV profiles. cellMN: whether the cell is malignant or not. b UMAP plot colored by the sub-populations of epithelial cells. c Dot plot of the expression of marker genes for the epithelial cell sub-populations. d Bar plot of the bootstrap proportions of epithelial cell sub-populations within each measured sample. e The epithelial cell sub-population proportions in tumor lesions (red) or the adjacent normal tissues (blue) from the four MPLC patients. Data represent mean ± s.d. **P < 0.01, t test, unpaired. f UMAP view of the clustering results (left) and CLDN2+ AT2 signatures (right) of epithelial cells from both the MPLCs patients and the dataset GSE131907. Batch effects were removed by harmony. The CLDN2+ AT2 signature was calculated based on the cell-wise gene set variation analysis, and the top15 ranked (based on P-values) marker genes for the CLDN2+ AT2 subtype were utilized as the signature gene set. g Pie plot of the data source of cells in Cluster 5 in (f). h Box plot of the differential expressions of CLDN2 between cells from the MPLC patients and GSE131907. Wilcox test, unpaired. i Immunohistochemistry (IHC) of CLDN2 expressions on the MPLCs samples. Samples NM_R_P2 and TM_R_P2 were taken as examples. Red border area was magnified and presented on the right. j Box plot of the differential CLDN2 IHC scores in MPLCs, IPM and solitary LUAD. Each IPM or MPLCs patient possessed two LUAD lesions at ipsilateral different lobes. Wilcox test, unpaired.CC BY · PubMed Central
Fig. 3 The CLDN2+ AT2 cells possess a stationary state. a, b Pseudotime trajectories of malignant epithelial cells in patient P2 are colored by the pseudotime (a) and states (b). c Pseudotime trajectories splitted by epithelial cell subtypes in patient P2. d Box plot of differences in pseudotimes between AT2 and CLDN2+ AT2 cells. Wilcox test, unpaired. e Heatmap of the pseudotime-dependent expression alterations of epithelial subtype marker genes. f Pathway enrichment results based on the marker genes of each epithelial subtype. Colors represent different subtypes. P: hypergeometric distribution. g Violin plot of the expressions of CLDN2-relevant cellular senescence marker genes in different epithelial cell subtypes. h Violin plot of the differential expression of CLDN2-relevant cellular senescence marker genes between CLDN2+ AT2 cells from the tumor and normal tissues. Wilcox test, unpaired. ****P < 0.0001.
Fig. 3 The CLDN2+ AT2 cells possess a stationary state. a, b Pseudotime trajectories of malignant epithelial cells in patient P2 are colored by the pseudotime (a) and states (b). c Pseudotime trajectories splitted by epithelial cell subtypes in patient P2. d Box plot of differences in pseudotimes between AT2 and CLDN2+ AT2 cells. Wilcox test, unpaired. e Heatmap of the pseudotime-dependent expression alterations of epithelial subtype marker genes. f Pathway enrichment results based on the marker genes of each epithelial subtype. Colors represent different subtypes. P: hypergeometric distribution. g Violin plot of the expressions of CLDN2-relevant cellular senescence marker genes in different epithelial cell subtypes. h Violin plot of the differential expression of CLDN2-relevant cellular senescence marker genes between CLDN2+ AT2 cells from the tumor and normal tissues. Wilcox test, unpaired. ****P < 0.0001.CC BY · PubMed Central
Fig. 4 Cell–cell interactions in MPLCs. a Heatmap of the cell–cell interactions between different cell types. The row and column, respectively, stand for the source and target cell types of the interactions. The top and right colored bar plot respectively represent the sum of column and row of values displayed in the heatmap. b Scatter plot of the interaction strength of different cell types. c Bubble plot of the interactions originated from the CLDN2+ AT2 cells and mediated by MDK. d Bar plot of the summarized communication probabilities on signaling pathways based on the interactions from fibroblast cells to CLDN2+ AT2 cells. e UMAP plot of the subpopulations of fibroblast cells. Myo: myofibroblast, SMC: smooth muscle cells. f Bar plot of the average proportions of each fibroblast cell sub-population in tumor and tumor-adjacent tissues. Data represent mean ± s.d. *P < 0.05, t test, unpaired.
Fig. 4 Cell–cell interactions in MPLCs. a Heatmap of the cell–cell interactions between different cell types. The row and column, respectively, stand for the source and target cell types of the interactions. The top and right colored bar plot respectively represent the sum of column and row of values displayed in the heatmap. b Scatter plot of the interaction strength of different cell types. c Bubble plot of the interactions originated from the CLDN2+ AT2 cells and mediated by MDK. d Bar plot of the summarized communication probabilities on signaling pathways based on the interactions from fibroblast cells to CLDN2+ AT2 cells. e UMAP plot of the subpopulations of fibroblast cells. Myo: myofibroblast, SMC: smooth muscle cells. f Bar plot of the average proportions of each fibroblast cell sub-population in tumor and tumor-adjacent tissues. Data represent mean ± s.d. *P < 0.05, t test, unpaired.CC BY · PubMed Central
Fig. 5 Spatial features of different cell types in MPLCs. a UMAP plot of 37616 spatial spots colored by cell types. The cell types of each spot were predicted by integrating the ST-seq data with the scRNA-seq data. b Spatial RNA-seq barcoded spots of the samples from patients P1 and P2, labeled by the predicted cell types. c Box plot of the difference of consistent scores of spots from tumor and normal tissues of the same patient in terms of different dominant cell types. d Box plot of the difference of consistent scores of spots from different tumor lesions of the same patient in terms of different dominant cell types. e Spatial spots colored by the predicted dominant epithelial cell subtypes. Four samples were displayed as examples. f Box plot of the difference of consistent scores of the spatial spots dominated by different epithelial cell subtypes. g Violin plot of the difference of consistent scores of spots from tumor and normal tissues in terms of different dominant epithelial cell subtypes. Kruskal test, unpaired.
Fig. 5 Spatial features of different cell types in MPLCs. a UMAP plot of 37616 spatial spots colored by cell types. The cell types of each spot were predicted by integrating the ST-seq data with the scRNA-seq data. b Spatial RNA-seq barcoded spots of the samples from patients P1 and P2, labeled by the predicted cell types. c Box plot of the difference of consistent scores of spots from tumor and normal tissues of the same patient in terms of different dominant cell types. d Box plot of the difference of consistent scores of spots from different tumor lesions of the same patient in terms of different dominant cell types. e Spatial spots colored by the predicted dominant epithelial cell subtypes. Four samples were displayed as examples. f Box plot of the difference of consistent scores of the spatial spots dominated by different epithelial cell subtypes. g Violin plot of the difference of consistent scores of spots from tumor and normal tissues in terms of different dominant epithelial cell subtypes. Kruskal test, unpaired.CC BY · PubMed Central
Fig. 6 The cellular and molecular profiles of different histologic patterns in MPLC-LUAD. a Pathological classification of malignant regions into histologic patterns including lepidic type (PR1), acinar type (PR2), micropapillary type (PR3), minimally invasive (PRm) and adenocarcinoma in situ (PRa). b The main cell type compositions of the pathological regions across the four investigated samples. c Boxplot of the proportions of different epithelial cell sub-populations in the pathological regions across all the investigated samples. t test, unpaired. AT2 and CLDN2+ AT2 are, respectively, compared to the other sub-populations. d Violin plot of the spatially resolved high expression of PDZK1IP1 in the region PR1. e KM-plot of the survival curves of patients in GSE30219. The patients were separated into two groups based on the expression of PDZK1IP1. f Bar plot of the mean fold change of PR3 marker genes shared by the three observed samples. g, h KM-plot of the survival curves of TCGA-LUAD patients. The patients were separated into two groups according to whether the expression of RANBP1 (g) and MDH2 (h) was higher than the median level. i. Spatial neighbors (the nearest three circles of spots) of the malignant regions. Colors represent different malignant regions. Sample TM_R_P3 is displayed as one example. j Box plot of the difference of cell compositions between the malignant regions and corresponding spatial neighbors. t test, unpaired.
Fig. 6 The cellular and molecular profiles of different histologic patterns in MPLC-LUAD. a Pathological classification of malignant regions into histologic patterns including lepidic type (PR1), acinar type (PR2), micropapillary type (PR3), minimally invasive (PRm) and adenocarcinoma in situ (PRa). b The main cell type compositions of the pathological regions across the four investigated samples. c Boxplot of the proportions of different epithelial cell sub-populations in the pathological regions across all the investigated samples. t test, unpaired. AT2 and CLDN2+ AT2 are, respectively, compared to the other sub-populations. d Violin plot of the spatially resolved high expression of PDZK1IP1 in the region PR1. e KM-plot of the survival curves of patients in GSE30219. The patients were separated into two groups based on the expression of PDZK1IP1. f Bar plot of the mean fold change of PR3 marker genes shared by the three observed samples. g, h KM-plot of the survival curves of TCGA-LUAD patients. The patients were separated into two groups according to whether the expression of RANBP1 (g) and MDH2 (h) was higher than the median level. i. Spatial neighbors (the nearest three circles of spots) of the malignant regions. Colors represent different malignant regions. Sample TM_R_P3 is displayed as one example. j Box plot of the difference of cell compositions between the malignant regions and corresponding spatial neighbors. t test, unpaired.CC BY · PubMed Central
Fig. 7 Molecular and cellular commonness and differences between lesions within the same MPLCs patient. a Scatter plot of the differential expressions of genes in the two different tumor lesions comparing to the corresponding adjacent normal tissues in each of the four MPLC patients. The x-axis represents the average log2FC (avg_logFC) computed by comparing the tumor and normal tissues in the inferior lobe (TIVSNI) of one patient. The y-axis represents the average log2FC (avg_logFC) computed by comparing the tumor and normal tissues in the other diseased lobe (TOthersVSNOthers) of one patient. The point colors represent the significance type. b Summary of the number of different significant types of genes identified based on each patient. c Summary of the number of different significant types of genes identified based on each cell type and each patient. d Seven Genes showed expressional change in all four MPLCs patients in certain cell types. e Box plot of the seven gene expressions in normal and tumor tissues based on the TCGA-LUAD dataset (p-value: kruskal test). f Violin plot of the expressions of TNFRSF18 across T&NK cell subpopulations. g Violin plot of the expressions of TNFRSF18 across all samples. h Spatially featured plot of the expressions of TNFRSF18 in two samples of P1.
Fig. 7 Molecular and cellular commonness and differences between lesions within the same MPLCs patient. a Scatter plot of the differential expressions of genes in the two different tumor lesions comparing to the corresponding adjacent normal tissues in each of the four MPLC patients. The x-axis represents the average log2FC (avg_logFC) computed by comparing the tumor and normal tissues in the inferior lobe (TIVSNI) of one patient. The y-axis represents the average log2FC (avg_logFC) computed by comparing the tumor and normal tissues in the other diseased lobe (TOthersVSNOthers) of one patient. The point colors represent the significance type. b Summary of the number of different significant types of genes identified based on each patient. c Summary of the number of different significant types of genes identified based on each cell type and each patient. d Seven Genes showed expressional change in all four MPLCs patients in certain cell types. e Box plot of the seven gene expressions in normal and tumor tissues based on the TCGA-LUAD dataset (p-value: kruskal test). f Violin plot of the expressions of TNFRSF18 across T&NK cell subpopulations. g Violin plot of the expressions of TNFRSF18 across all samples. h Spatially featured plot of the expressions of TNFRSF18 in two samples of P1.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 51 references

Cited by

See all 39

Metadata

Authors
Wang, Y., Chen, D., Liu, Y., Shi, D., Duan, C., Li, J., Shi, X., Zhang, Y., Yu, Z., Sun, N., Wang, W., Ma, Y., Xu, X., Otkur, W., Liu, X., Xia, T., Qi, H., Piao, H.-L., & Liu, H.-X.
Affiliations
  • China Medical University (TW)
  • Dalian Institute of Chemical Physics (CN)
  • Chinese Academy of Sciences (CN)
Corresponding author
Piao, Hai-long
Venue
Cell Death & Disease
Published
2023-07-25
Volume
14
Issue
7
Pages
462-462
ISSN
2041-4889 (ISSN-L)
OpenAlex
W4385230455
Cited by
39
References
51
Citations by year
2026: 12 · 2025: 13 · 2024: 14
FWCI
3.48
Type
journal article
Language
en
Open access
Licence
Locations
  • Cell Death and Disease (publishedVersion, cc-by)
  • SSRN Electronic Journal (acceptedVersion)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
  • National Natural Science Foundation of China (81972625)
  • Innovation program of science and research from the DICP, CAS
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Single-cell and spatial transcriptomics
  • Health Sciences › Medicine › Epidemiology › Multiple and Secondary Primary Cancers
  • Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Metastasis and carcinoma case studies
Keywords
multiple primary lung cancer, intrapulmonary metastasis, diagnostic biomarkers, tumor microenvironment
MeSH terms
Cell Communication, Epithelial Cells, Humans, Lung Neoplasms, Neoplasms, Multiple Primary, Gene Expression Profiling

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Multidirectional characterization of cellular composition and spatial architecture in human multiple primary lung cancers. https://app.cochat.ai/papers/10.1038/s41419-023-05992-w
The paper
Wang, Y., Chen, D., Liu, Y., Shi, D., Duan, C., Li, J., Shi, X., Zhang, Y., Yu, Z., Sun, N., Wang, W., Ma, Y., Xu, X., Otkur, W., Liu, X., Xia, T., Qi, H., Piao, H.-L., & Liu, H.-X. (2023). Multidirectional characterization of cellular composition and spatial architecture in human multiple primary lung cancers. Cell Death & Disease. https://doi.org/10.1038/s41419-023-05992-w

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.